Our Leadership
J. Allen Scoggin, PharmD, MPA
President/CEO
Dr. Scoggin is the Founder, President, and CEO of Med Communications. Prior to founding Med Communications, Allen served on the College of Pharmacy faculty of the University of Tennessee Health Sciences Center for 30 years. He graduated from the University of Tennessee with a BS in Pharmacy (1967) and Doctor of Pharmacy degree (1971). Allen also received the Masters in Public Administration from the University of Memphis (1982). Dr. Scoggin served as a Pharmacy Officer in the US Air Force BioMedical Science Corps from 1967 to 1970 (Otis Air Force Base, Massachusetts).
In 2025, Dr. Scoggin was inducted into The Society of Entrepreneurs. The Society, founded in 1991, recognizes business owners for their achievements, leadership, and involvement with the Memphis and Mid-South communities. Its members are Mid-South business owners, presidents, and other key executives who are established entrepreneurs and have exhibited personal business achievement, creativity, determination, integrity, leadership, self-direction, and the ability to transform a vision into a dynamic business accomplishment. Nomination to join is awarded by The Society’s members, and is a deep honor.
Running Med Communications is something Scoggin enjoys for both its challenges and its rewards. He credits his father for sparking his interest in business. As a teen, he helped his father in homebuilding and was fascinated by the process of planning and construction. He wanted to immediately go into the business out of high school, but his father insisted he go to college and that time in academia prepared him even further for life as an entrepreneur.
That journey has been rewarding. As he puts it: “We’re excited about growing the company, and we’re global. It’s just been an exciting venture.”
Elizabeth Schwartz, PharmD
Associate Director, Contact Center Operations
Liz is a pharmacist with broad experience across community pharmacy, specialty pharmacy, and medical information. She holds a Bachelor of Science in Biology with a minor in Business from the University of Alabama and earned her Doctor of Pharmacy from the University of Tennessee College of Pharmacy.
Prior to joining Med Communications in 2022, Liz gained valuable experience in both community and specialty pharmacy, including a focus on rare diseases and orphan drug therapies. Since joining Med Communications, she has served as a Medical Information Manager supporting clients in therapeutic areas such as vaccines, hematology/oncology, and neurology. She has also led client implementations, product launches, and expansion initiatives within the contact center, contributing to service excellence and operational growth.
Maria Anitan, MD
Global Head of Pharmacovigilance
Maria is an experienced pharmaceutical industry professional with more than 15 years in leadership roles covering pharmacovigilance, medical affairs, healthcare compliance, patient advocacy, General Data Protection Regulation (GDPR), medical education and communication, and clinical development, which she has practiced in the United States and Europe.
Maria graduated as a Medical Doctor in General Medicine from “Iuliu Hatieganu” Medicine and Pharmacy University in Cluj-Napoca, Romania. She joined the pharmaceutical industry from clinical practice and held different positions in Eli Lilly, Genzyme-Sanofi, UCB, and Ipsen, being involved in or leading multiple cross-functional projects in the areas of rare diseases, neurology, oncology, bone marrow transplant, and hematology. She is a subject matter expert for pharmacovigilance issues, regulatory interpretation and best practices, and management of safety data and analysis in both clinical trials and post-marketing around the world.
Liza Rinehart, PharmD
Director, Scientific Communications and Medical/Promotional Review
Liza received her PharmD from the University of Tennessee College of Pharmacy, completed an ASHP-accredited residency, and enjoyed a career in clinical pharmacy for 19+ years. Since joining the Med Communications team in 2014, she has gained experience in medical information contact center, medical affairs, promotional review, and scientific content development of many types of deliverables for multiple pharmaceutical and device companies. Liza has worked in numerous therapeutic areas, including oncology, rare diseases, vaccines, general medicine, neurology, neonatal intensive care, high-risk obstetrics, trauma, burn, and long-term care.
Ann Winter-Vann, PhD
Director, Regulatory Writing Services
Ann received her PhD in Molecular Cancer Biology from Duke University. Following a postdoc at the University of North Carolina at Chapel Hill, Ann transitioned into regulatory writing, where she supported numerous therapeutic areas, including rare disease, gastroenterology, ophthalmology, respiratory, immunology, and oncology (including CAR-T).
With more than 17 years of experience in regulatory writing, Ann has authored clinical research and regulatory documents for the US Food and Drug Administration, the European Medicines Agency, and submissions to China. Her document experience includes protocols, clinical study reports, submission documents, Investigator’s Brochures, and briefing packages, and she is an advocate for lean writing principles.
Ann is a Fellow and Past President of the American Medical Writers Association.